Aehr Test Systems, Inc. (AEHR) 股票分析

公司概述

Aehr Test Systems, Inc. specializes in delivering comprehensive test solutions designed for the testing, burning-in, and characterization of semiconductor devices across various stages of production, including wafer level, singulated die, and package part forms. The company operates within the Technology sector, specifically focusing on the Semiconductor Equipment & Materials industry, which positions it as a critical supplier for essential manufacturing infrastructure in the electronics supply chain. As of the latest data, the company maintains a market capitalization of $2.17 billion and employs approximately 136 individuals to support its operations in the United States, Asia, and Europe. With an annual revenue of $45.26 million, these valuation and scale figures indicate that while the firm holds a significant market capitalization relative to its current sales, it operates with a lean operational footprint typical of specialized equipment manufacturers. The disparity between the $2.17 billion market cap and the $45.26 million revenue suggests that the market values the company's future potential and intellectual property more heavily than its current top-line performance, reflecting high expectations for growth or dominance in niche semiconductor testing technologies.

财务健康

The company reported a total revenue of $45.26 million over the trailing twelve months, yet it recorded a net income of -$11,416,000 and an EBITDA of -$11,928,000. The substantial gap between the positive revenue and the negative net income reveals a challenging cost structure where expenses, likely driven by high R&D or operational costs, significantly outpace the revenue generated in the current period. Free cash flow stands at -$7,451,625, indicating that the company is currently consuming cash rather than generating liquidity, which limits its immediate financial flexibility to fund operations without external financing. Gross margin is reported at 30.7%, suggesting that the cost of goods sold consumes a significant portion of revenue before operating expenses are considered. However, the operating margin of -41.0% and profit margin of -25.2% highlight severe operational inefficiencies or high fixed cost burdens relative to current sales levels. The company holds $36.91 million in cash against $10.03 million in debt, resulting in a debt-to-equity ratio of 7.22. Despite the high leverage indicated by the debt-to-equity metric, the substantial cash reserves suggest the balance sheet has sufficient liquidity to cover short-term obligations, though the negative cash flow trend is a concern. The current ratio of 10.97 indicates an extremely strong position regarding short-term liquidity, with current assets far exceeding current liabilities. Return on Equity is -8.7% and Return on Assets is -6.1%, metrics that reveal that management is currently generating negative returns on the capital invested in the business and the assets utilized.

估值评估

The trailing P/E ratio is listed as N/A due to the company's lack of positive earnings, while the forward P/E ratio is extremely high at 519.70. This massive disparity between the trailing and forward P/E implies that the market is pricing in significant expected earnings growth to justify the current stock price, as current profitability does not support the valuation multiple. The price-to-book ratio stands at 16.74, indicating that the market is valuing the company at a substantial premium of roughly 16.7 times its book value, reflecting confidence in intangible assets or future earnings potential. The price-to-sales ratio is 47.86, and the EV/EBITDA is -179.32; these alternative metrics suggest that traditional earnings-based valuation models are not applicable, and investors are relying heavily on revenue multiples and growth prospects to assess value. The stock has traded between a 52-week high of $70.26 and a 52-week low of $6.58. Without the current price explicitly provided in the facts, the valuation context is defined by this extreme volatility range, showing the stock has experienced significant price discovery over the past year. The beta value is 2.29, which means the stock's price volatility is more than double that of the broader market, indicating that investors should expect significantly higher price swings in both directions compared to a standard market index.

Growth & Income

Revenue growth year-over-year is -43.7%, while earnings growth is N/A due to the absence of prior year positive earnings for comparison. The negative revenue growth rate indicates a contraction in sales, and since the company is already unprofitable, there is no earnings growth to accelerate relative to revenue; instead, the decline in sales exacerbates the loss-making financial profile. As a non-dividend payer, the company has a dividend yield of N/A and a payout ratio of 0.0%, meaning it retains all earnings rather than distributing them to shareholders. Given the company's current negative net income, the payout ratio is technically zero and not sustainable in a traditional sense, as there are no profits to distribute. Instead of paying dividends, the company reinvests its limited resources, though currently negative, into maintaining its test solution portfolio and R&D efforts to eventually achieve profitability. The overall growth and income profile for Aehr Test Systems, Inc. is characterized by significant revenue contraction, negative profitability, high valuation multiples driven by future expectations, and a complete absence of dividend income for shareholders.